Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$208M |
| 2 |
NVIDIA
NVDA
|
+$74.8M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$49M |
| 4 |
Merck
MRK
|
+$20.3M |
| 5 |
GE Aerospace
GE
|
+$19.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celanese
CE
|
+$14.3M |
| 2 |
ExxonMobil
XOM
|
+$11.5M |
| 3 |
APA Corp
APA
|
+$11.5M |
| 4 |
Kenvue
KVUE
|
+$10.7M |
| 5 |
Mattel
MAT
|
+$10.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.43% |
| 2 | Industrials | 11.88% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Healthcare | 9.07% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
John Wiley & Sons Class A
WLY
$2.62B
| $264K | ﹤0.01% |
5,463
-1,880
| -26% | -$86.3K |
|
1277
CareDx
CDNA
$2.51B
| $262K | ﹤0.01% |
+8,405
| New | +$209K |
|
1278
MGP Ingredients
MGPI
$387M
| $262K | ﹤0.01% |
+3,142
| New | +$260K |
|
1279
Hillman Solutions
HLMN
$1.63B
| $259K | ﹤0.01% |
24,573
-41,960
| -63% | -$405K |
|
1280
Ryman Hospitality Properties
RHP
$8.86B
| $259K | ﹤0.01% |
+2,417
| New | +$247K |
|
1281
Adeia
ADEA
$2.89B
| $257K | ﹤0.01% |
21,537
+575
| +3% | +$6.67K |
|
1282
Brighthouse Financial
BHF
$3.01B
| $256K | ﹤0.01% |
5,677
-2,825
| -33% | -$127K |
|
1283
AAR Corp
AIR
$5.43B
| $254K | ﹤0.01% |
3,890
-1,163
| -23% | -$76.9K |
|
1284
GigaCloud Technology
GCT
$1.77B
| $254K | ﹤0.01% |
11,051
+2,397
| +28% | +$57.5K |
|
1285
Huntington Bancshares
HBAN
$34.4B
| $254K | ﹤0.01% |
17,266
-4,886
| -22% | -$69.4K |
|
1286
Ionis Pharmaceuticals
IONS
$9.93B
| $251K | ﹤0.01% |
6,262
| – | – |
|
1287
Diebold Nixdorf
DBD
$2.37B
| $251K | ﹤0.01% |
+5,610
| New | +$232K |
|
1288
Ryan Specialty Holdings
RYAN
$11.1B
| $249K | ﹤0.01% |
3,751
-2,197
| -37% | -$137K |
|
1289
First Citizens BancShares
FCNCA
$24.7B
| $249K | ﹤0.01% |
135
-7
| -5% | -$13.4K |
|
1290
Wolfspeed
WOLF
$1.34B
| $248K | ﹤0.01% |
25,520
-79,080
| -76% | -$1.16M |
|
1291
HCI Group
HCI
$2.27B
| $247K | ﹤0.01% |
+2,309
| New | +$219K |
|
1292
Chemours
CC
$2.4B
| $244K | ﹤0.01% |
12,013
-26,870
| -69% | -$549K |
|
|
ALTR
1293
DELISTED
Altair Engineering Inc
ALTR
| $242K | ﹤0.01% |
+2,536
| New | +$230K |
|
1294
Targa Resources
TRGP
$64.1B
| $242K | ﹤0.01% |
1,636
+53
| +3% | +$7.46K |
|
1295
Coeur Mining
CDE
$21.6B
| $240K | ﹤0.01% |
+34,859
| New | +$217K |
|
1296
Entegris
ENTG
$22B
| $239K | ﹤0.01% |
2,127
-6,310
| -75% | -$747K |
|
1297
Materion
MTRN
$4.83B
| $239K | ﹤0.01% |
+2,137
| New | +$238K |
|
1298
KB Home
KBH
$3.39B
| $239K | ﹤0.01% |
2,788
-1,408
| -34% | -$113K |
|
|
EQC
1299
DELISTED
Equity Commonwealth
EQC
| $238K | ﹤0.01% |
11,947
+23
| +0.2% | +$458 |
|
1300
Albany International
AIN
$1.68B
| $238K | ﹤0.01% |
+2,674
| New | +$235K |
|
Similar funds
Joel Greenblatt's Q3 2024 Portfolio in Review
As of Q3 2024, Joel Greenblatt held 1,552 positions worth $9.67B, up 25% from $7.72B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Joel Greenblatt deployed $1.31B of net new capital in Q3 2024, opening 145 new positions and adding to 741 existing holdings. Its largest new stake was AST SpaceMobile: 520,630 shares worth $13.6M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Celanese, an estimated $14.3M trimmed.
- Joel Greenblatt's largest Q3 2024 buy was AST SpaceMobile: 520,630 shares worth $13.6M.
- Joel Greenblatt added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $208M increase.
- Joel Greenblatt's biggest Q3 2024 reduction was Celanese, cutting an estimated $14.3M.
- Joel Greenblatt fully exited Corteva in Q3 2024, selling an estimated $9.36M.
- Joel Greenblatt's ten largest holdings make up 25% of its $9.67B portfolio in Q3 2024.
- Joel Greenblatt opened 145 new positions and closed 150 in Q3 2024.
- Joel Greenblatt's portfolio value rose 25% quarter-over-quarter to $9.67B.
Based on Gotham Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.